Results 141 to 150 of about 5,616 (255)
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock +8 more
wiley +1 more source
[Association of cigarette consumption, nicotine derivatives and cannabis with periodontal disease. A review]. [PDF]
Valenzuela-Torres OY +2 more
europepmc +1 more source
‘I'd rather have worse gums than worse lungs’: Young people's views of nicotine pouches in the UK
Abstract Background and aims Nicotine pouches entered the UK market in 2019. Although research has shown that young people's prevalence of use has been low, it has been reported to be increasing and a cause for concern. This paper reports the findings of the first qualitative study in the UK to explore the views of 14–16 year olds' knowledge, awareness
Andy MacGregor +7 more
wiley +1 more source
Ecological competition in the oral mycobiome of Hispanic adults living in Puerto Rico associates with periodontitis. [PDF]
Acosta-Pagán K +4 more
europepmc +1 more source
Abstract Background and aims Lower risk guidelines for safer levels of cannabis use could help to reduce the health burden posed by cannabis use disorder (CUD). We aimed to estimate risk thresholds for CUD based on delta‐9‐tetrahydrocannabinol (THC) consumption using standard THC units (1 unit = 5 mg THC).
Rachel Lees Thorne +9 more
wiley +1 more source
Characteristics of cannabis warnings in the United States: A content analysis. [PDF]
Kowitt SD +7 more
europepmc +1 more source
Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era
Abstract Background Canada's 2018 legalization of non‐medical cannabis was positioned as a public health initiative, intended to shift cannabis use from criminalization to regulation. Since then, cannabis access and consumption have grown significantly but the systems used to monitor cannabis‐related harms have not kept pace.
Anees Bahji
wiley +1 more source
Abstract Background and aims Currently, there is no data‐driven cannabis reduction metric using biochemical verification, which represents a significant gap in cannabis harm reduction research, treatment and policy. Using aggregated data from 7 cannabis use disorder treatment trials, the aims of this analysis were to 1) determine if decreases in self ...
Erin A. McClure +6 more
wiley +1 more source
Impact of partial cannabis legalisation in Luxembourg: An interdisciplinary perspective. [PDF]
Berndt N, Schneider S, Oliverio S.
europepmc +1 more source

